Inactivation of Serine Proteinase Inhibitors (Serpins) in Human Plasma by Reactive Oxidants
- 1 January 1988
- journal article
- research article
- Published by Walter de Gruyter GmbH in Biological Chemistry Hoppe-Seyler
- Vol. 369 (2) , 1337-1342
- https://doi.org/10.1515/bchm3.1988.369.2.1337
Abstract
Activated polymorphonuclear neutrophils (PMN) and macrophages generate oxidizing agents similar to or identical with N-chloroamines. Mimicking this oxidation in normal human plasma by usage of chloramine T (CT), we observed an oxidant concentration dependent inactivating effect on plasma .alpha.2-plasmin inhibitor (.alpha.2-PI), antithrombin III (AT III), and .alpha.1-proteinase inhibitor (.alpha.1-PI). 20-50 .mu.mol CT/ml plasma are necessary for almost complete inactivation of .alpha.2-PI and AT III-activity, i.e. about 2-5 times the dose necessary for inactivation of .alpha.1-PI which has already been classified as "oxidant sensitive". The inactivation of .alpha.1-PI, .alpha.2-PI and AT III in plasma by oxidants is the result of a specific oxidative damage since C1-inhibitor, serine proteinases and complexes of plasmin and .alpha.2-PI were chloramine resistant under the conditions used. According to our results, the amount of chloramines released by 1 .times. 106 activated PMN, namely ca. 10 nmol (see Weiss et al. Science 222 625-628, 1983) would be sufficient to destroy .alpha.1-PI and .alpha.2-PI activity of 1.5 and 0.4 .mu.l of human plasma, respectively. Consequently, activated leukocytes may be able to create a microenvironment in which elastase as well as plasma and thrombin can display their proteolytic activity unchecked by their regulator proteins. Oxidation may provide a general basis for altering enzyme/inhibitor balances.This publication has 26 references indexed in Scilit:
- Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.Journal of Clinical Investigation, 1987
- Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.Journal of Clinical Investigation, 1987
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.Journal of Clinical Investigation, 1986
- Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritisBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites.Journal of Clinical Investigation, 1984
- Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity.Proceedings of the National Academy of Sciences, 1982
- Elastolytic Activity in Pulmonary Lavage Fluid from Patients with Adult Respiratory-Distress SyndromeNew England Journal of Medicine, 1981
- Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluidBiochemical and Biophysical Research Communications, 1980
- Release of Inflammatory Mediators from Stimulated NeutrophilsNew England Journal of Medicine, 1980